244 related articles for article (PubMed ID: 18344521)
1. Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection.
Kristensen LS; Mikeska T; Krypuy M; Dobrovic A
Nucleic Acids Res; 2008 Apr; 36(7):e42. PubMed ID: 18344521
[TBL] [Abstract][Full Text] [Related]
2. Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM.
Kristensen LS; Wojdacz TK; Thestrup BB; Wiuf C; Hager H; Hansen LL
BMC Cancer; 2009 Dec; 9():453. PubMed ID: 20025721
[TBL] [Abstract][Full Text] [Related]
3. Nested multigene MSP/DHPLC method for analyzing promoter hypermethylation status in clinical samples.
Divine KK; Liechty KC; Crume KC; Belinsky SA
Biotechniques; 2006 Jan; 40(1):40, 42, 44 passim. PubMed ID: 16454038
[No Abstract] [Full Text] [Related]
4. Frequent but borderline methylation of p16 (INK4a) and TIMP3 in medulloblastoma and sPNET revealed by quantitative analyses.
Mühlisch J; Bajanowski T; Rickert CH; Roggendorf W; Würthwein G; Jürgens H; Frühwald MC
J Neurooncol; 2007 May; 83(1):17-29. PubMed ID: 17206475
[TBL] [Abstract][Full Text] [Related]
5. Closed-tube PCR methods for locus-specific DNA methylation analysis.
Candiloro IL; Mikeska T; Dobrovic A
Methods Mol Biol; 2011; 791():55-71. PubMed ID: 21913071
[TBL] [Abstract][Full Text] [Related]
6. Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation.
Candiloro IL; Mikeska T; Dobrovic A
Epigenetics; 2011 Apr; 6(4):500-7. PubMed ID: 21364322
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
8. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer.
Calmon MF; Colombo J; Carvalho F; Souza FP; Filho JF; Fukuyama EE; Camargo AA; Caballero OL; Tajara EH; Cordeiro JA; Rahal P
Cancer Genet Cytogenet; 2007 Feb; 173(1):31-7. PubMed ID: 17284367
[TBL] [Abstract][Full Text] [Related]
9. High-resolution melting-based quantitative analysis of RASSF1 methylation in breast cancer.
Stuopelytė K; Daniūnaitė K; Laurinavičienė A; Ostapenko V; Jarmalaitė S
Medicina (Kaunas); 2013; 49(2):78-83. PubMed ID: 23888343
[TBL] [Abstract][Full Text] [Related]
10. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation.
Wojdacz TK; Dobrovic A
Nucleic Acids Res; 2007; 35(6):e41. PubMed ID: 17289753
[TBL] [Abstract][Full Text] [Related]
11. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
[TBL] [Abstract][Full Text] [Related]
12. A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues.
Zhou J; Cao J; Lu Z; Liu H; Deng D
BMC Med Genet; 2011 May; 12():67. PubMed ID: 21569495
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the p16(Ink4a) tumor suppressor gene 5'-CpG island in breast cancer.
Nielsen NH; Roos G; Emdin SO; Landberg G
Cancer Lett; 2001 Feb; 163(1):59-69. PubMed ID: 11163109
[TBL] [Abstract][Full Text] [Related]
14. Development and application of a multiplex PCR procedure for the detection of DNA methylation in colorectal cancer.
Anacleto C; Rossi B; Lopes A; Soares FA; Rocha JC; Caballero O; Camargo AA; Simpson AJ; Pena SD
Oncol Rep; 2005 Feb; 13(2):325-8. PubMed ID: 15643519
[TBL] [Abstract][Full Text] [Related]
15. Methylation-Sensitive High Resolution Melting (MS-HRM).
Hussmann D; Hansen LL
Methods Mol Biol; 2018; 1708():551-571. PubMed ID: 29224163
[TBL] [Abstract][Full Text] [Related]
16. Association of aberrant DNA methylation with clinicopathological features in breast cancer.
Tserga A; Michalopoulos NV; Levidou G; Korkolopoulou P; Zografos G; Patsouris E; Saetta AA
Oncol Rep; 2012 May; 27(5):1630-8. PubMed ID: 22159596
[TBL] [Abstract][Full Text] [Related]
17. A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples.
Dimitrakopoulos L; Vorkas PA; Georgoulias V; Lianidou ES
BMC Cancer; 2012 Oct; 12():486. PubMed ID: 23088560
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
[TBL] [Abstract][Full Text] [Related]
19. PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment.
Kristensen LS; Hansen LL
Clin Chem; 2009 Aug; 55(8):1471-83. PubMed ID: 19520761
[TBL] [Abstract][Full Text] [Related]
20. Methylation-specific loop-mediated isothermal amplification for detecting hypermethylated DNA in simplex and multiplex formats.
Zerilli F; Bonanno C; Shehi E; Amicarelli G; Adlerstein D; Makrigiorgos GM
Clin Chem; 2010 Aug; 56(8):1287-96. PubMed ID: 20551384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
